The three-day conference known as the 19th Annual Symposium of the International Cannabinoid Research Society (ICRS) is scheduled to have 250 researchers worldwide attend from July 8 to July 11 at the Pheasant Run Resort in St. Charles, Illinois.

Topics discussed (warning: PDF) will be scientific based analysis of the therapeutic use of cannabinoids to treat numerous conditions:

• Cancer
• Social anxiety disorder
• Alcoholism
• Acne
• Stroke

Aside from trying to prove there are more ways of fighting cancer and trying to put ProActive out of business, the ICRS is 400+ members strong, all who are researchers in the field of “endogenous, plant-derived and synthetic cannabinoids”.

Bad news fellas, if you’re chronic with the chronic, chances are the personal army residing in your testicles won’t be operating at full potential.

Research into the effects of long-time marijuana use on the male reproductive system has shown that sperm with enhanced cannabinoid / endocannabinoid signaling results in compromised fertilizing capacity. Translated from doctor speak, that means a sperm’s capacity to bust through the wall of an egg is reduced, which makes it much harder to create the mini-me you always wanted.

As of right now, we can’t find any specific numbers as far as the usage that might significantly affect a pot smoker – no time range or general daily amount – so there is still no way to tell if you’re screwed or not. Vanderbilt University has a page dedicated to their endocannabinoid research with links to abstracts of their specific papers on the topic, it will satisfy your daily quota of medical jargon.

If the happy ending you’re used to resembles the video above, don’t sweat it. If not, we’ll keep everyone updated when new information is released.